ICAAC 46th

Title
In Vitro Activity of the New Azole BAL4815 and other Antifungal Agents against Candida Bloodstream Isolates (click for details)
In Vitro Activity of the New Azole Isavuconazole (BAL 4815) Compared with Six other Antifungal Agents against 155 Cryptococcus neoformans Isolates from Cuba (click for details)
Activity In Vitro of 27 Combinations of Licensed Antifungal Agents against Scedosporium apiospermum (Sa) and Scedosporium prolificans (Sp). (click for details)
Impact of a Caspofungin (CAS) Restriction Policy on Appropriateness of Use and the Financial Implications in a Large Tertiary Hospital. (click for details)
Body Mass Index (BMI) Significantly Increased with Macrolide Treatment in Patients with Chronic Necrotizing Pulmonary Aspergillosis. (click for details)
Micafungin (MCF) Alone or in Combination with Other Licensed Antifungal Therapy (OLAT) in Bone Marrow Transplant (BMT) Recipients with Invasive Aspergillosis (IA). (click for details)
Cross Reactivity in the Platelia Aspergillus Galactomannan Antigenemia Assay Caused by Histoplasmosis. (click for details)
Efficacy of New Polymeric Guandine against Yeasts and Filamentous Fungi. (click for details)
Evaluation of the Efficacy of Liposomal Amphotericin B (L-AmB) or Caspofungin (CAS) in the Treatment of Experimental Candida albicans Catheter Infection (CI) Using the Antifungal-Lock Technique (ALT). (click for details)
Gliotoxin Induces Concentration-Dependent Apoptosis in Alveolar Epithelial Type II Pneumocytes. (click for details)

Pages

Subscribe to ICAAC 46th